Deramiocel for DMD: HOPE-3 Cell Therapy Trial Outcomes
Analyze the HOPE-3 Phase 3 trial results for Deramiocel, an investigational cell therapy for Duchenne muscular dystrophy. Review PUL v2.0 data and FDA status.
Back to Articles
Articles tagged with “dmd-cardiomyopathy”